The change to open listing on the NL Prescription Drug Program reduces the administrative burden of prescribers by eliminating the special authorization process that had been in place.
Government is expanding prescription coverage for long-acting muscarinic antagonist (LAMAs) inhalers, used in the treatment of Chronic Obstructive Pulmonary Disease. The change to open listing on the NL Prescription Drug Program reduces the administrative burden of prescribers by eliminating the special authorization process that had been in place. This will ensure NLPDP beneficiaries have timely access to these inhalers for the treatment of their COPD.
Norris Point man and Corner Brook woman caught with cocaine near Howley this week
Two men arrested, one with a Canada Wide warrant, with drugs, cash and more in Corner Brook last night
Military munition found in Bay St. George has been safely disposed of at a secure location
Moose fencing coming on the TCH from Glide Lake Road to Little Harbour
Government calls for a seven-day food fishery for us all
